$SHOM's Recent News was Featured by

New Post Public Reply Private Reply Replies (0) Message Board
zigzagman
$SHOM's Recent News was Featured by InternetHealthManagement.com

Homemedy.com Brings Back Doctors Making House Calls

By Peter Lucas - September 23, 2016 16

In the days of black-and-white TV it was common for doctors to treat sick patients in their homes. A startup aims to revive the practice in the internet age.

Southern Home Medical Solutions Inc. has developed Homemedy.com, an online platform that lets patients request house calls, as a way to stimulate a more personal relationship between patient and physician, the company says.

“The nature of the relationship between patient and doctor is less personal today,” says CEO Miquel Dotres. “Using technology to help facilitate house calls can help reverse that trend.”

Patients can log on to Homemedy.com to schedule in-home visits with a range of physicians, including those specialized in pediatrics, internal medicine and family practice. They can also book a visit by a licensed nurse practitioner. Homemedy.com will launch in Port Charlotte, Fla., in the first quarter of 2017 and later expand to Miami and Jacksonville.

Southern Home Medical is targeting these markets because they have large populations of seniors and families likely to welcome house calls from doctors or nurse practitioners, Dotres says.

“Our platform provides consumers an opportunity to reduce travel and wait times at a doctor’s office and receive care in a comfortable and personal setting,” Dotres says.

Patients logging on to Homemedy.com or using the Homemedy mobile app can find doctors and schedule appointments. After an in-home visit, the service will provide patients an electronic summary of the doctor’s notes, which can be downloaded and shared with their primary care physician.

If follow-up procedures such as for blood tests or x-rays are required and can’t be performed at the patient’s home, the attending practitioner can schedule an appointment for the service at another location or make a patient referral. Patient billing for Homemedy.com is handled through another Southern Home Medical subsidiary.

While most doctors don’t make house calls, Homemedy.com is likely to appeal to medical group practices looking to expand patient services without incurring the expense of setting up and staffing another location, the company says. Homemedy.com is currently recruiting physicians in Florida, but declines to reveal the number of practitioners signed so far.

Homemedy.com plans to charge patients a $99 flat fee per visit. Homemedy.com will receive 10% to 15% of that fee. In comparison, visiting a doctor’s office visit can cost $150, Dotres says. The company will also charge additional fees when patients use its platform for other services, such as filling an online prescription, which doctors can order at the time of the visit.

Plans are also in the works to introduce a line of wearable devices connected to Homemedy.com for tracking blood pressure, oxygen levels, heart rate and other vital signs. The devices are still in the development stage and expected to range in price from $100 to $350, depending on the functionality. Data gathered through the devices can be shared with a patient’s doctor through the Homemedy.com. Southern Home Medical is developing the devices with CES Technology Ltd., a healthcare technology development company based in Taiwan. Southern Home acquired CES for an undisclosed sum in August.

Southern Home Medical Solutions provides medical staffing, such as certified nurses, billing and customer service representatives, and equipment to doctor’s offices, clinics, nursing homes and rehabilitation centers.

https://www.internethealthmanagement.com/2016...ouse-calls
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Virse Revolutionizes Creative Production with AI Canvas

Updated Category News Views 156

A New Era in Creative Workflows These days, the design world is getting a major shake-up thanks to Virse's innovative AI-driven workspace. Based out of Dover, this new system isn't just about boosting tech for the sake of it; it's about making creative production a symphony rather than a cacophony. And, let me tell ya, any time I've loaded up on coffee to prep for a brand...

Continue Reading
MPLX Reports Q3 2026 Results with 12.5% Distribution Hike

Updated Category News Views 34

Another Distribution Hike: 12.5% Bump in Q3 Man, MPLX is at it again, boosting that quarterly distribution by a hefty 12.5%. That's three years running now, marking it up to $4.84 per unit on an annualized basis. In an industry where reliability sometimes feels like a relic, this kind of consistency is a sweet serenade to any income-focused investor's ears. "MPLX is...

Continue Reading
Newcomers, Veterans Elevate NYSE's Tokenization Efforts

Updated Category News Views 100

Breaking New Ground at the NYSE When the bell rings at the NYSE these days, it's not just marking the start of another trading session. It's the sound of change clanging its way onto Wall Street. On November 3, 2026, the NYSE threw its hat deeper into the tokenization ring, a game-changer perhaps. They've roped in some big guns—Securitize, tZERO, Broadridge Financial...

Continue Reading
Lupin Launches HIV Treatment, Secures 180-Day Exclusivity

Updated Category News Views 18

Lupin's Market Move: A Big Step in HIV Treatment There's a fresh gust blowing in the pharmaceutical skies today, as Lupin leaps ahead with the launch of their Raltegravir Tablets in the U.S. The company just bagged FDA approval, putting them on the front lines with a high-stake 180-day exclusivity period for their generic version. For investors keeping tabs on pharma...

Continue Reading
Canton Fair Showcases Cutting-Edge Healthcare Tech 2026

Updated Category News Views 41

Innovation Steals the Show in Guangzhou In a world where tech evolution rarely takes a breather, the 140th Canton Fair's Intelligent Healthcare Zone is like a breath of fresh air. Picture it: a whole arena pulsing with futuristic healthcare gizmos from October 31 to November 4, 2026—it's as if tomorrow swung by for a sneak peek. The event brings together everything from...

Continue Reading
Yunji Rolls Out AI Robots at EquipHotel Paris 2026

Updated Category News Views 90

AI Takes Center Stage in Hospitality When someone mentions a new revolution in hospitality, I usually roll my eyes. But this time, Yunji Technology (HKEX: 02670) is bringing something to the table that's hard to ignore. They’re out in full force at EquipHotel Paris 2026, flaunting their AI-powered collection of service bots with the kind of confidence that says, 'We're...

Continue Reading
Reju Partners with Six Mills to Advance Textile Regeneration

Updated Category News Views 203

Big Moves in Textile Regeneration Now here's a move that's got the fabric world buzzing: Reju, the scrappy textile-to-textile regenerative powerhouse, is teaming up with six mills spread across Europe and the U.S. They’re setting the stage to crank up their polyester recycling game and flood the market with sustainable, eco-friendly fabrics. It's a bold step toward...

Continue Reading
Himel's Latest: Powering Industry and Homes Alike

Updated Category News Views 46

Switching Gears: Himel's New Electrical Frontiers Ah, the humming of motors, the click of switches—it's the backbone of any decent industrial setup or modern home today. Himel isn't messing around when it comes to staying on top of these evolving electrical needs, both in gritty industrial settings and our cozy living rooms. This time, they're taking a serious crack at...

Continue Reading
XPENG Eyes South Korea Entry with Industry Veteran

Updated Category News Views 142

A Veteran's Task in a New Territory Piling onto its international ambitions, XPENG has roped in Lee Man-sik, a seasoned auto industry professional, to break into South Korea. South Korea isn’t just another market—it’s one of the toughest stages for the automotive industry. The customers there are sharp, with a keen eye for tech and quality. So XPENG, trading under...

Continue Reading
Samsung Biologics Hits 'Negligible' ESG Risk Milestone

Updated Category News Views 26

Samsung Biologics Achieves a Low-Risk Triumph You gotta hand it to Samsung Biologics for hitting a 'Negligible Risk' rating. Their latest score? A cool 9.0. That’s like walking into the pharmaceuticals room and getting a standing ovation. It's no small feat—climbing up from a 'Low Risk' rating to the top tier in Morningstar Sustainalytics' playbook. For us spectating...

Continue Reading

Top 5 Most Recently Viewed Articles

EnFin Solar Receivables Trust Receives Ratings from KBRA

Updated Category News Views 525

EnFin Residential Solar Receivables Trust 2024-2 Overview Recently, KBRA has assigned preliminary ratings to three classes of notes that total $324.54 million, issued by EnFin Residential Solar Receivables Trust 2024-2, commonly referred to as EnFin 2024-2. This asset-backed securities (ABS) transaction is secured by residential solar loans, aiming to support solar energy...

Continue Reading
Taxbit's Digital Accord to Shape Future of Compliance

Updated Category News Views 257

Taxbit's Digital Accord: Building a Future in Compliance The third edition of the Digital Accord gathers influential regulators and innovators to strategize the future of digital asset compliance and transparency. Global Leaders Meet in London Gathered in this major global capital, executives from various sectors will dive deep into the essential frameworks that will...

Continue Reading
Centene Corporation Q1 2025 Report Showcases Strong Growth

Updated Category News Views 588

Centene Corporation Reports Strong First Quarter 2025 Results Centene Corporation (NYSE: CNC) has made a notable impact in the healthcare sector, showcasing impressive financial achievements in its first-quarter results. The company reported adjusted diluted EPS of $2.90 for the quarter, reflecting a substantial increase of 28% from $2.26 in the same quarter the previous...

Continue Reading
Theratechnologies Faces Temporary EGRIFTA SV Supply Challenges

Updated Category News Views 111

Theratechnologies Faces Temporary Challenges with EGRIFTA SV Supply MONTREAL - Theratechnologies Inc. (NASDAQ: THTX), a well-known biopharmaceutical company, is currently tackling a potential supply interruption regarding its product EGRIFTA SV. This situation has arisen from an unexpected shutdown at a contract manufacturer’s facility, which followed an FDA inspection....

Continue Reading
Miami International Holdings Achieves Record Trading Figures

Updated Category News Views 281

Overview of Trading Results Miami International Holdings, Inc. (MIH) has recently shared its impressive trading results for December and the entire year of 2024, showcasing strong performance across its U.S. exchange subsidiaries including MIAX, MIAX Pearl, MIAX Emerald, and MIAX Sapphire, as well as MIAX Futures. December 2024 and Full-Year Volume Highlights The overall...

Continue Reading